White matter hyperintensity accumulation during treatment of late-life depression

Neuropsychopharmacology

Volumn 40, Issue 13, 2015, Pages 3027-3035

  Khalaf, Alexander ^a   Edelman, Kathryn ^a   Tudorascu, Dana ^a   Andreescu, Carmen ^a   Reynolds, Charles F ^a   Aizenstein, Howard ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DULOXETINE; ESCITALOPRAM; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BRAIN ANALYSIS; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; FUNCTIONAL NEUROIMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; LATE LIFE DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REMISSION; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WHITE MATTER HYPERINTENSITY; BRAIN; DEPRESSIVE DISORDER; LONGITUDINAL STUDY; ONSET AGE; ORGAN SIZE; PATHOLOGY; WHITE MATTER;

AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; TREATMENT OUTCOME; WHITE MATTER;

EID: 84947485908     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.158     Document Type: Article

References (75)

1. Aizenstein HJ, Andreescu C, Edelman KL, Cochran JL, Price J, Butters MA, et al. (2011). fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry 168: 1075-1082.
2. Aizenstein HJ, Butters MA, Figurski JL, Stenger VA, Reynolds CF III, Carter CS (2005). Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 58: 290-296.
3. Aizenstein HJ, Khalaf A, Walker SE, Andreescu C (2014). Magnetic resonance imaging predictors of treatment response in late-life depression. J Geriatr Psychiatry Neurol 27: 24-32.
4. Alexopoulos GS (2005). Depression in the elderly. Lancet 365: 1961-1970.
5. Alexopoulos GS, Glatt CE, Hoptman MJ, Kanellopoulos D, Murphy CF, Kelly RE Jr., et al. (2010). BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression. J Affect Disord 125: 262-268.
6. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO (2002). Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry 159: 1929-1932.
7. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997). 'Vascular depression' hypothesis. Arch Gen Psychiatry 54: 915-922.
8. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Feder M, Einhorn A., et al. (1996). Recovery in geriatric depression. Arch Gen Psychiatry 53: 305-312.
9. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. (2008). Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 165: 238-244.
10. Andreescu C, Butters MA, Begley A, Rajji T, Wu M, Meltzer CC, et al. (2008). Gray matter changes in late life depression-a structural MRI analysis. Neuropsychopharmacology 33: 2566-2572.
11. Beekman AT, Copeland JR, Prince MJ (1999). Review of community prevalence of depression in later life. Br J Psychiatry 174: 307-311.
12. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF 3rd, et al. (2008). Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialog Clin Neurosci 10: 345-357.
13. Campbell S, Marriott M, Nahmias C, MacQueen GM (2004). Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161: 598-607.
14. Casten RJ, Rovner BW, Shmuely-Dulitzki Y, Pasternak RE, Pelchat R, Ranen N (1999). Predictors of recovery from major depression among geriatric psychiatry inpatients: the importance of caregivers beliefs. Int Psychogeriatr/IPA 11: 149-157.
15. Chen PS, McQuoid DR, Payne ME, Steffens DC (2006). White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study. Int Psychogeriatr/IPA 18: 445-456.
16. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC (2008). Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 42: 177-184.
17. Chimowitz MI, Awad IA, Furlan AJ (1989). Periventricular lesions on MRI. Facts and theories. Stroke 20: 963-967.
18. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. (2011). Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77: 461-468.
19. Dew MA, Reynolds CF 3rd, Houck PR, Hall M, Buysse DJ, Frank E, et al. (1997). Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 54: 1016-1024.
20. Dotson VM, Zonderman AB, Kraut MA, Resnick SM (2013). Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women. Int J Geriatr Psychiatry 28: 66-74.
21. Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, et al. (2012). Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry 201: 40-45.
22. Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O'Brien JT, Ford GA (2007). Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 254: 713-721.
23. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PWet al (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851-855.
24. Garcia-Pena C, Wagner FA, Sanchez-Garcia S, Espinel-Bermudez C, Juarez-Cedillo T, Perez-Zepeda M, et al. (2013). Late-life depressive symptoms: prediction models of change. J Affect Disord 150: 886-894.
25. Grool AM, van der Graaf Y, Vincken KL, Witkamp TD, Mali WP, Geerlings MI (2013). Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR study. J Neurol 260: 197-206.
26. Hajszan T, MacLusky NJ, Leranth C (2005). Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci 21: 1299-1303.
27. Halperin D, Reber G (2007). Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9: 47-59.
28. Hannestad J, Taylor WD, McQuoid DR, Payne ME, Krishnan KR, Steffens DC, et al. (2006). White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatry 21: 1193-1198.
29. Heiden A, Kettenbach J, Fischer P, Schein B, Ba-Ssalamah A, Frey R, et al. (2005). White matter hyperintensities and chronicity of depression. J Psychiatric Res 39: 285-293.
30. Heo M, Murphy CF, Meyers BS (2007). Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis. Am J Geriatr Psychiatry 15: 899-905.
31. Herrmann LL, Le Masurier M, Ebmeier KP (2008). White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 79: 619-624.
32. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012). Fsl. NeuroImage 62: 782-790.
33. Katon W, Unutzer J, Russo J (2010). Major depression: the importance of clinical characteristics and treatment response to prognosis. Depr Anxiety 27: 19-26.
34. Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, et al. (2008). Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) report. Am J Geriatr Psychiatry 16: 58-64.
35. Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, et al. (2004). Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry 55: 390-397.
36. Kupfer DJ (2005). Achieving adequate outcomes in geriatric depression: standardized criteria for remission. J Clin Psychopharmacol 25(Suppl 1): S24-S28.
37. Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF 3rd, Alexopoulos GS, Bruce ML, et al. (1997). Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 278: 1186-1190.
38. Lenze E, Cross D, McKeel D, Neuman RJ, Sheline YI (1999). White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 156: 1602-1607.
39. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, et al. (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 100: 1387-1392.
40. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110.
41. Mulsant BH, Houck PR, Gildengers AG, Andreescu C, Dew MA, Pollock BG, et al. (2006). What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? J Clin Psychopharmacol 26: 113-120.
42. Nelson JC, Delucchi KL, Schneider LS (2013). Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J psychiatry 170: 651-659.
43. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B (1998). Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ 317: 982-984.
44. Reynolds CF 3rd, Dew MA, Frank E, Begley AE, Miller MD, Cornes C, et al. (1998). Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 155: 795-799.
45. Reynolds CF III, Kupfer DJ (1999). Depression and aging: a look to the future. Psychiatr Serv 50: 1167-1172.
46. Rosano C, Becker J, Lopez O, Lopez-Garcia P, Carter CS, Newman A, et al. (2005). Morphometric analysis of gray matter volume in demented older adults: exploratory analysis of the cardiovascular health study brain MRI database. Neuroepidemiology 24: 221-229.
47. Saghafi R, Brown C, Butters MA, Cyranowski J, Dew MA, Frank E, et al. (2007). Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry 22: 1141-1146.
48. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP (1999). MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 53: 132-139.
49. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996). Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908-3913.
50. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31: 1487-1505.
51. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. (2009). Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 169: 2128-2139.
52. Steffens DC, Chung H, Krishnan KR, Longstreth WT Jr., Carlson M, Burke GL (2008). Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 39: 857-862.
53. Streitburger DP, Moller HE, Tittgemeyer M, Hund-Georgiadis M, Schroeter ML, Mueller K (2012). Investigating structural brain changes of dehydration using voxel-based morphometry. PLoS One 7: e44195.
54. Taylor WD, Bae JN, MacFall JR, Payne ME, Provenzale JM, Steffens DC, et al. (2007). Widespread effects of hyperintense lesions on cerebral white matter structure. Am J Roentgenol 188: 1695-1704.
55. Taylor WD, Kudra K, Zhao Z, Steffens DC, MacFall JR (2014). Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study. J Affect Disord 162: 8-11.
56. Taylor WD, MacFall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, et al. (2005). Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res 139: 1-7.
57. Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, et al. (2003). White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 60: 1090-1096.
58. Taylor WD, Zhao Z, Ashley-Koch A, Payne ME, Steffens DC, Krishnan RR, et al. (2013). Fiber tract-specific white matter lesion severity findings in late-life depression and by AGTR1 A1166C genotype. Hum Brain Mapp 34: 295-303.
59. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, et al. (2007). White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry 191: 212-217.
60. Teper E, O'Brien JT (2008). Vascular factors and depression. Int J Geriatr Psychiatry 23: 993-1000.
61. Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, et al. (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 59: 785-792.
62. University of Pittsburgh, National Institutes of Health (2008). Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults. National Institutes of Health: Bethesda, MD.
63. University of Pittsburgh, National Institutes of Health (2009). Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY). National Institutes of Health: Bethesda, MD.
64. University of Pittsburgh, National Institutes of Health (2010). ADAPT: Addressing Depression and Pain Together. National Institutes of Health: Bethesda, MDBethesda, MD.
65. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008). Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39: 2712-2719.
66. Vermetten E, Vythilingam M, Southwick SM, Charney DS, Bremner JD (2003). Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 54: 693-702.
67. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161: 1957-1966.
68. Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, et al. (2004). Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 56: 101-112.
69. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S (2004). Fiber tract-based atlas of human white matter anatomy. Radiology 230: 77-87.
70. Weeke P, Jensen A, Folke F, Gislason GH, Olesen JB, Andersson C, et al. (2012). Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 92: 72-79.
71. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, et al. (2009). Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 53: 950-958.
72. Wu CS, Wang SC, Cheng YC, Gau SS (2011). Association of cerebrovascular events with antidepressant use: a casecrossover study. Am J Psychiatry 168: 511-521.
73. Wu M, Carmichael O, Lopez-Garcia P, Carter CS, Aizenstein HJ (2006a). Quantitative comparison of AIR, SPM, and the fully deformable model for atlas-based segmentation of functional and structural MR images. Hum Brain Mapp 27: 747-754.
74. Wu M, Rosano C, Butters M, Whyte E, Nable M, Crooks R, et al. (2006b). A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res 148: 133-142.
75. Zimmerman M, Posternak MA, Chelminski I (2004). Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 38: 577-582.